Global PD-1 and PD-L1 Inhibitors Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global PD-1 and PD-L1 Inhibitors market size is predicted to grow from US$ 55740 million in 2025 to US$ 174560 million in 2031; it is expected to grow at a CAGR of 21.0% from 2025 to 2031.
PD-1 inhibitors and PD-L1 inhibitors are a group of checkpoint inhibitors being developed for the treatment of cancer. PD-1 and PD-L1 are both proteins present on the surface of cells. Immune checkpoint inhibitors such as these are emerging as a front-line treatment for several types of cancer.
North America is the largest consumption place, with a consumption market share nearly 60.40% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 20.66%.Market competition is intense. Merck, Bristol-Myers Squibb, Roche, AstraZeneca, Ono Pharmaceutical etc. are the leaders of the industry.
LP Information, Inc. (LPI) ' newest research report, the “PD-1 and PD-L1 Inhibitors Industry Forecast” looks at past sales and reviews total world PD-1 and PD-L1 Inhibitors sales in 2024, providing a comprehensive analysis by region and market sector of projected PD-1 and PD-L1 Inhibitors sales for 2025 through 2031. With PD-1 and PD-L1 Inhibitors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world PD-1 and PD-L1 Inhibitors industry.
This Insight Report provides a comprehensive analysis of the global PD-1 and PD-L1 Inhibitors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on PD-1 and PD-L1 Inhibitors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global PD-1 and PD-L1 Inhibitors market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for PD-1 and PD-L1 Inhibitors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global PD-1 and PD-L1 Inhibitors.
This report presents a comprehensive overview, market shares, and growth opportunities of PD-1 and PD-L1 Inhibitors market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global PD-1 and PD-L1 Inhibitors market?
What factors are driving PD-1 and PD-L1 Inhibitors market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do PD-1 and PD-L1 Inhibitors market opportunities vary by end market size?
How does PD-1 and PD-L1 Inhibitors break out by Type, by Application?
The global PD-1 and PD-L1 Inhibitors market size is predicted to grow from US$ 55740 million in 2025 to US$ 174560 million in 2031; it is expected to grow at a CAGR of 21.0% from 2025 to 2031.
PD-1 inhibitors and PD-L1 inhibitors are a group of checkpoint inhibitors being developed for the treatment of cancer. PD-1 and PD-L1 are both proteins present on the surface of cells. Immune checkpoint inhibitors such as these are emerging as a front-line treatment for several types of cancer.
North America is the largest consumption place, with a consumption market share nearly 60.40% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 20.66%.Market competition is intense. Merck, Bristol-Myers Squibb, Roche, AstraZeneca, Ono Pharmaceutical etc. are the leaders of the industry.
LP Information, Inc. (LPI) ' newest research report, the “PD-1 and PD-L1 Inhibitors Industry Forecast” looks at past sales and reviews total world PD-1 and PD-L1 Inhibitors sales in 2024, providing a comprehensive analysis by region and market sector of projected PD-1 and PD-L1 Inhibitors sales for 2025 through 2031. With PD-1 and PD-L1 Inhibitors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world PD-1 and PD-L1 Inhibitors industry.
This Insight Report provides a comprehensive analysis of the global PD-1 and PD-L1 Inhibitors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on PD-1 and PD-L1 Inhibitors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global PD-1 and PD-L1 Inhibitors market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for PD-1 and PD-L1 Inhibitors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global PD-1 and PD-L1 Inhibitors.
This report presents a comprehensive overview, market shares, and growth opportunities of PD-1 and PD-L1 Inhibitors market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- PD-1 Inhibitors
- PD-L1 Inhibitors
- Solid Tumors
- Blood-related Tumors
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Bristol-Myers Squibb
- Roche
- AstraZeneca
- Ono Pharmaceutical
- Regeneron
- Innovent
- Hengrui Medicine
- Junshi Biosciences
- Merck KGaA
What is the 10-year outlook for the global PD-1 and PD-L1 Inhibitors market?
What factors are driving PD-1 and PD-L1 Inhibitors market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do PD-1 and PD-L1 Inhibitors market opportunities vary by end market size?
How does PD-1 and PD-L1 Inhibitors break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global PD-1 and PD-L1 Inhibitors Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for PD-1 and PD-L1 Inhibitors by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for PD-1 and PD-L1 Inhibitors by Country/Region, 2020, 2024 & 2031
2.2 PD-1 and PD-L1 Inhibitors Segment by Type
2.2.1 PD-1 Inhibitors
2.2.2 PD-L1 Inhibitors
2.3 PD-1 and PD-L1 Inhibitors Sales by Type
2.3.1 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2020-2025)
2.3.2 Global PD-1 and PD-L1 Inhibitors Revenue and Market Share by Type (2020-2025)
2.3.3 Global PD-1 and PD-L1 Inhibitors Sale Price by Type (2020-2025)
2.4 PD-1 and PD-L1 Inhibitors Segment by Application
2.4.1 Solid Tumors
2.4.2 Blood-related Tumors
2.5 PD-1 and PD-L1 Inhibitors Sales by Application
2.5.1 Global PD-1 and PD-L1 Inhibitors Sale Market Share by Application (2020-2025)
2.5.2 Global PD-1 and PD-L1 Inhibitors Revenue and Market Share by Application (2020-2025)
2.5.3 Global PD-1 and PD-L1 Inhibitors Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global PD-1 and PD-L1 Inhibitors Breakdown Data by Company
3.1.1 Global PD-1 and PD-L1 Inhibitors Annual Sales by Company (2020-2025)
3.1.2 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Company (2020-2025)
3.2 Global PD-1 and PD-L1 Inhibitors Annual Revenue by Company (2020-2025)
3.2.1 Global PD-1 and PD-L1 Inhibitors Revenue by Company (2020-2025)
3.2.2 Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Company (2020-2025)
3.3 Global PD-1 and PD-L1 Inhibitors Sale Price by Company
3.4 Key Manufacturers PD-1 and PD-L1 Inhibitors Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers PD-1 and PD-L1 Inhibitors Product Location Distribution
3.4.2 Players PD-1 and PD-L1 Inhibitors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PD-1 AND PD-L1 INHIBITORS BY GEOGRAPHIC REGION
4.1 World Historic PD-1 and PD-L1 Inhibitors Market Size by Geographic Region (2020-2025)
4.1.1 Global PD-1 and PD-L1 Inhibitors Annual Sales by Geographic Region (2020-2025)
4.1.2 Global PD-1 and PD-L1 Inhibitors Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic PD-1 and PD-L1 Inhibitors Market Size by Country/Region (2020-2025)
4.2.1 Global PD-1 and PD-L1 Inhibitors Annual Sales by Country/Region (2020-2025)
4.2.2 Global PD-1 and PD-L1 Inhibitors Annual Revenue by Country/Region (2020-2025)
4.3 Americas PD-1 and PD-L1 Inhibitors Sales Growth
4.4 APAC PD-1 and PD-L1 Inhibitors Sales Growth
4.5 Europe PD-1 and PD-L1 Inhibitors Sales Growth
4.6 Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Growth
5 AMERICAS
5.1 Americas PD-1 and PD-L1 Inhibitors Sales by Country
5.1.1 Americas PD-1 and PD-L1 Inhibitors Sales by Country (2020-2025)
5.1.2 Americas PD-1 and PD-L1 Inhibitors Revenue by Country (2020-2025)
5.2 Americas PD-1 and PD-L1 Inhibitors Sales by Type (2020-2025)
5.3 Americas PD-1 and PD-L1 Inhibitors Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC PD-1 and PD-L1 Inhibitors Sales by Region
6.1.1 APAC PD-1 and PD-L1 Inhibitors Sales by Region (2020-2025)
6.1.2 APAC PD-1 and PD-L1 Inhibitors Revenue by Region (2020-2025)
6.2 APAC PD-1 and PD-L1 Inhibitors Sales by Type (2020-2025)
6.3 APAC PD-1 and PD-L1 Inhibitors Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe PD-1 and PD-L1 Inhibitors by Country
7.1.1 Europe PD-1 and PD-L1 Inhibitors Sales by Country (2020-2025)
7.1.2 Europe PD-1 and PD-L1 Inhibitors Revenue by Country (2020-2025)
7.2 Europe PD-1 and PD-L1 Inhibitors Sales by Type (2020-2025)
7.3 Europe PD-1 and PD-L1 Inhibitors Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa PD-1 and PD-L1 Inhibitors by Country
8.1.1 Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Country (2020-2025)
8.1.2 Middle East & Africa PD-1 and PD-L1 Inhibitors Revenue by Country (2020-2025)
8.2 Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Type (2020-2025)
8.3 Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of PD-1 and PD-L1 Inhibitors
10.3 Manufacturing Process Analysis of PD-1 and PD-L1 Inhibitors
10.4 Industry Chain Structure of PD-1 and PD-L1 Inhibitors
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 PD-1 and PD-L1 Inhibitors Distributors
11.3 PD-1 and PD-L1 Inhibitors Customer
12 WORLD FORECAST REVIEW FOR PD-1 AND PD-L1 INHIBITORS BY GEOGRAPHIC REGION
12.1 Global PD-1 and PD-L1 Inhibitors Market Size Forecast by Region
12.1.1 Global PD-1 and PD-L1 Inhibitors Forecast by Region (2026-2031)
12.1.2 Global PD-1 and PD-L1 Inhibitors Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global PD-1 and PD-L1 Inhibitors Forecast by Type (2026-2031)
12.7 Global PD-1 and PD-L1 Inhibitors Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
13.1.3 Merck PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Bristol-Myers Squibb
13.2.1 Bristol-Myers Squibb Company Information
13.2.2 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
13.2.3 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Bristol-Myers Squibb Main Business Overview
13.2.5 Bristol-Myers Squibb Latest Developments
13.3 Roche
13.3.1 Roche Company Information
13.3.2 Roche PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
13.3.3 Roche PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Roche Main Business Overview
13.3.5 Roche Latest Developments
13.4 AstraZeneca
13.4.1 AstraZeneca Company Information
13.4.2 AstraZeneca PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
13.4.3 AstraZeneca PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 AstraZeneca Main Business Overview
13.4.5 AstraZeneca Latest Developments
13.5 Ono Pharmaceutical
13.5.1 Ono Pharmaceutical Company Information
13.5.2 Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
13.5.3 Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Ono Pharmaceutical Main Business Overview
13.5.5 Ono Pharmaceutical Latest Developments
13.6 Regeneron
13.6.1 Regeneron Company Information
13.6.2 Regeneron PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
13.6.3 Regeneron PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Regeneron Main Business Overview
13.6.5 Regeneron Latest Developments
13.7 Innovent
13.7.1 Innovent Company Information
13.7.2 Innovent PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
13.7.3 Innovent PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Innovent Main Business Overview
13.7.5 Innovent Latest Developments
13.8 Hengrui Medicine
13.8.1 Hengrui Medicine Company Information
13.8.2 Hengrui Medicine PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
13.8.3 Hengrui Medicine PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Hengrui Medicine Main Business Overview
13.8.5 Hengrui Medicine Latest Developments
13.9 Junshi Biosciences
13.9.1 Junshi Biosciences Company Information
13.9.2 Junshi Biosciences PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
13.9.3 Junshi Biosciences PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Junshi Biosciences Main Business Overview
13.9.5 Junshi Biosciences Latest Developments
13.10 Merck KGaA
13.10.1 Merck KGaA Company Information
13.10.2 Merck KGaA PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
13.10.3 Merck KGaA PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Merck KGaA Main Business Overview
13.10.5 Merck KGaA Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. PD-1 and PD-L1 Inhibitors Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. PD-1 and PD-L1 Inhibitors Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of PD-1 Inhibitors
Table 4. Major Players of PD-L1 Inhibitors
Table 5. Global PD-1 and PD-L1 Inhibitors Sales byType (2020-2025) & (L)
Table 6. Global PD-1 and PD-L1 Inhibitors Sales Market Share byType (2020-2025)
Table 7. Global PD-1 and PD-L1 Inhibitors Revenue byType (2020-2025) & ($ million)
Table 8. Global PD-1 and PD-L1 Inhibitors Revenue Market Share byType (2020-2025)
Table 9. Global PD-1 and PD-L1 Inhibitors Sale Price byType (2020-2025) & (USD/ml)
Table 10. Global PD-1 and PD-L1 Inhibitors Sale by Application (2020-2025) & (L)
Table 11. Global PD-1 and PD-L1 Inhibitors Sale Market Share by Application (2020-2025)
Table 12. Global PD-1 and PD-L1 Inhibitors Revenue by Application (2020-2025) & ($ million)
Table 13. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Application (2020-2025)
Table 14. Global PD-1 and PD-L1 Inhibitors Sale Price by Application (2020-2025) & (USD/ml)
Table 15. Global PD-1 and PD-L1 Inhibitors Sales by Company (2020-2025) & (L)
Table 16. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Company (2020-2025)
Table 17. Global PD-1 and PD-L1 Inhibitors Revenue by Company (2020-2025) & ($ millions)
Table 18. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Company (2020-2025)
Table 19. Global PD-1 and PD-L1 Inhibitors Sale Price by Company (2020-2025) & (USD/ml)
Table 20. Key Manufacturers PD-1 and PD-L1 Inhibitors Producing Area Distribution and Sales Area
Table 21. Players PD-1 and PD-L1 Inhibitors Products Offered
Table 22. PD-1 and PD-L1 Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global PD-1 and PD-L1 Inhibitors Sales by Geographic Region (2020-2025) & (L)
Table 26. Global PD-1 and PD-L1 Inhibitors Sales Market Share Geographic Region (2020-2025)
Table 27. Global PD-1 and PD-L1 Inhibitors Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global PD-1 and PD-L1 Inhibitors Sales by Country/Region (2020-2025) & (L)
Table 30. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Country/Region (2020-2025)
Table 31. Global PD-1 and PD-L1 Inhibitors Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas PD-1 and PD-L1 Inhibitors Sales by Country (2020-2025) & (L)
Table 34. Americas PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2020-2025)
Table 35. Americas PD-1 and PD-L1 Inhibitors Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas PD-1 and PD-L1 Inhibitors Sales byType (2020-2025) & (L)
Table 37. Americas PD-1 and PD-L1 Inhibitors Sales by Application (2020-2025) & (L)
Table 38. APAC PD-1 and PD-L1 Inhibitors Sales by Region (2020-2025) & (L)
Table 39. APAC PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2020-2025)
Table 40. APAC PD-1 and PD-L1 Inhibitors Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC PD-1 and PD-L1 Inhibitors Sales byType (2020-2025) & (L)
Table 42. APAC PD-1 and PD-L1 Inhibitors Sales by Application (2020-2025) & (L)
Table 43. Europe PD-1 and PD-L1 Inhibitors Sales by Country (2020-2025) & (L)
Table 44. Europe PD-1 and PD-L1 Inhibitors Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe PD-1 and PD-L1 Inhibitors Sales byType (2020-2025) & (L)
Table 46. Europe PD-1 and PD-L1 Inhibitors Sales by Application (2020-2025) & (L)
Table 47. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Country (2020-2025) & (L)
Table 48. Middle East & Africa PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales byType (2020-2025) & (L)
Table 50. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Application (2020-2025) & (L)
Table 51. Key Market Drivers & Growth Opportunities of PD-1 and PD-L1 Inhibitors
Table 52. Key Market Challenges & Risks of PD-1 and PD-L1 Inhibitors
Table 53. Key IndustryTrends of PD-1 and PD-L1 Inhibitors
Table 54. PD-1 and PD-L1 Inhibitors Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. PD-1 and PD-L1 Inhibitors Distributors List
Table 57. PD-1 and PD-L1 Inhibitors Customer List
Table 58. Global PD-1 and PD-L1 Inhibitors SalesForecast by Region (2026-2031) & (L)
Table 59. Global PD-1 and PD-L1 Inhibitors RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas PD-1 and PD-L1 Inhibitors SalesForecast by Country (2026-2031) & (L)
Table 61. Americas PD-1 and PD-L1 Inhibitors Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC PD-1 and PD-L1 Inhibitors SalesForecast by Region (2026-2031) & (L)
Table 63. APAC PD-1 and PD-L1 Inhibitors Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe PD-1 and PD-L1 Inhibitors SalesForecast by Country (2026-2031) & (L)
Table 65. Europe PD-1 and PD-L1 Inhibitors RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa PD-1 and PD-L1 Inhibitors SalesForecast by Country (2026-2031) & (L)
Table 67. Middle East & Africa PD-1 and PD-L1 Inhibitors RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global PD-1 and PD-L1 Inhibitors SalesForecast byType (2026-2031) & (L)
Table 69. Global PD-1 and PD-L1 Inhibitors RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global PD-1 and PD-L1 Inhibitors SalesForecast by Application (2026-2031) & (L)
Table 71. Global PD-1 and PD-L1 Inhibitors RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Merck Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
Table 74. Merck PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2020-2025)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. Bristol-Myers Squibb Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 78. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
Table 79. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2020-2025)
Table 80. Bristol-Myers Squibb Main Business
Table 81. Bristol-Myers Squibb Latest Developments
Table 82. Roche Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 83. Roche PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
Table 84. Roche PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2020-2025)
Table 85. Roche Main Business
Table 86. Roche Latest Developments
Table 87. AstraZeneca Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 88. AstraZeneca PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
Table 89. AstraZeneca PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2020-2025)
Table 90. AstraZeneca Main Business
Table 91. AstraZeneca Latest Developments
Table 92. Ono Pharmaceutical Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 93. Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
Table 94. Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2020-2025)
Table 95. Ono Pharmaceutical Main Business
Table 96. Ono Pharmaceutical Latest Developments
Table 97. Regeneron Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 98. Regeneron PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
Table 99. Regeneron PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2020-2025)
Table 100. Regeneron Main Business
Table 101. Regeneron Latest Developments
Table 102. Innovent Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 103. Innovent PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
Table 104. Innovent PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2020-2025)
Table 105. Innovent Main Business
Table 106. Innovent Latest Developments
Table 107. Hengrui Medicine Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 108. Hengrui Medicine PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
Table 109. Hengrui Medicine PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2020-2025)
Table 110. Hengrui Medicine Main Business
Table 111. Hengrui Medicine Latest Developments
Table 112. Junshi Biosciences Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 113. Junshi Biosciences PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
Table 114. Junshi Biosciences PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2020-2025)
Table 115. Junshi Biosciences Main Business
Table 116. Junshi Biosciences Latest Developments
Table 117. Merck KGaA Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 118. Merck KGaA PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
Table 119. Merck KGaA PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2020-2025)
Table 120. Merck KGaA Main Business
Table 121. Merck KGaA Latest Developments
LIST OFFIGURES
Figure 1. Picture of PD-1 and PD-L1 Inhibitors
Figure 2. PD-1 and PD-L1 Inhibitors Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global PD-1 and PD-L1 Inhibitors Sales Growth Rate 2020-2031 (L)
Figure 7. Global PD-1 and PD-L1 Inhibitors Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. PD-1 and PD-L1 Inhibitors Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. PD-1 and PD-L1 Inhibitors Sales Market Share by Country/Region (2024)
Figure 10. PD-1 and PD-L1 Inhibitors Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of PD-1 Inhibitors
Figure 12. Product Picture of PD-L1 Inhibitors
Figure 13. Global PD-1 and PD-L1 Inhibitors Sales Market Share byType in 2025
Figure 14. Global PD-1 and PD-L1 Inhibitors Revenue Market Share byType (2020-2025)
Figure 15. PD-1 and PD-L1 Inhibitors Consumed in SolidTumors
Figure 16. Global PD-1 and PD-L1 Inhibitors Market: SolidTumors (2020-2025) & (L)
Figure 17. PD-1 and PD-L1 Inhibitors Consumed in Blood-relatedTumors
Figure 18. Global PD-1 and PD-L1 Inhibitors Market: Blood-relatedTumors (2020-2025) & (L)
Figure 19. Global PD-1 and PD-L1 Inhibitors Sale Market Share by Application (2024)
Figure 20. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Application in 2025
Figure 21. PD-1 and PD-L1 Inhibitors Sales by Company in 2025 (L)
Figure 22. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Company in 2025
Figure 23. PD-1 and PD-L1 Inhibitors Revenue by Company in 2025 ($ millions)
Figure 24. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Company in 2025
Figure 25. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Geographic Region in 2025
Figure 27. Americas PD-1 and PD-L1 Inhibitors Sales 2020-2025 (L)
Figure 28. Americas PD-1 and PD-L1 Inhibitors Revenue 2020-2025 ($ millions)
Figure 29. APAC PD-1 and PD-L1 Inhibitors Sales 2020-2025 (L)
Figure 30. APAC PD-1 and PD-L1 Inhibitors Revenue 2020-2025 ($ millions)
Figure 31. Europe PD-1 and PD-L1 Inhibitors Sales 2020-2025 (L)
Figure 32. Europe PD-1 and PD-L1 Inhibitors Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales 2020-2025 (L)
Figure 34. Middle East & Africa PD-1 and PD-L1 Inhibitors Revenue 2020-2025 ($ millions)
Figure 35. Americas PD-1 and PD-L1 Inhibitors Sales Market Share by Country in 2025
Figure 36. Americas PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2020-2025)
Figure 37. Americas PD-1 and PD-L1 Inhibitors Sales Market Share byType (2020-2025)
Figure 38. Americas PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2020-2025)
Figure 39. United States PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC PD-1 and PD-L1 Inhibitors Sales Market Share by Region in 2025
Figure 44. APAC PD-1 and PD-L1 Inhibitors Revenue Market Share by Region (2020-2025)
Figure 45. APAC PD-1 and PD-L1 Inhibitors Sales Market Share byType (2020-2025)
Figure 46. APAC PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2020-2025)
Figure 47. China PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 51. India PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Country in 2025
Figure 55. Europe PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2020-2025)
Figure 56. Europe PD-1 and PD-L1 Inhibitors Sales Market Share byType (2020-2025)
Figure 57. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2020-2025)
Figure 58. Germany PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 59.France PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 60. UK PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Market Share byType (2020-2025)
Figure 65. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2020-2025)
Figure 66. Egypt PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 69.Turkey PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of PD-1 and PD-L1 Inhibitors in 2025
Figure 72. Manufacturing Process Analysis of PD-1 and PD-L1 Inhibitors
Figure 73. Industry Chain Structure of PD-1 and PD-L1 Inhibitors
Figure 74. Channels of Distribution
Figure 75. Global PD-1 and PD-L1 Inhibitors Sales MarketForecast by Region (2026-2031)
Figure 76. Global PD-1 and PD-L1 Inhibitors Revenue Market ShareForecast by Region (2026-2031)
Figure 77. Global PD-1 and PD-L1 Inhibitors Sales Market ShareForecast byType (2026-2031)
Figure 78. Global PD-1 and PD-L1 Inhibitors Revenue Market ShareForecast byType (2026-2031)
Figure 79. Global PD-1 and PD-L1 Inhibitors Sales Market ShareForecast by Application (2026-2031)
Figure 80. Global PD-1 and PD-L1 Inhibitors Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global PD-1 and PD-L1 Inhibitors Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for PD-1 and PD-L1 Inhibitors by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for PD-1 and PD-L1 Inhibitors by Country/Region, 2020, 2024 & 2031
2.2 PD-1 and PD-L1 Inhibitors Segment by Type
2.2.1 PD-1 Inhibitors
2.2.2 PD-L1 Inhibitors
2.3 PD-1 and PD-L1 Inhibitors Sales by Type
2.3.1 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2020-2025)
2.3.2 Global PD-1 and PD-L1 Inhibitors Revenue and Market Share by Type (2020-2025)
2.3.3 Global PD-1 and PD-L1 Inhibitors Sale Price by Type (2020-2025)
2.4 PD-1 and PD-L1 Inhibitors Segment by Application
2.4.1 Solid Tumors
2.4.2 Blood-related Tumors
2.5 PD-1 and PD-L1 Inhibitors Sales by Application
2.5.1 Global PD-1 and PD-L1 Inhibitors Sale Market Share by Application (2020-2025)
2.5.2 Global PD-1 and PD-L1 Inhibitors Revenue and Market Share by Application (2020-2025)
2.5.3 Global PD-1 and PD-L1 Inhibitors Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global PD-1 and PD-L1 Inhibitors Breakdown Data by Company
3.1.1 Global PD-1 and PD-L1 Inhibitors Annual Sales by Company (2020-2025)
3.1.2 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Company (2020-2025)
3.2 Global PD-1 and PD-L1 Inhibitors Annual Revenue by Company (2020-2025)
3.2.1 Global PD-1 and PD-L1 Inhibitors Revenue by Company (2020-2025)
3.2.2 Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Company (2020-2025)
3.3 Global PD-1 and PD-L1 Inhibitors Sale Price by Company
3.4 Key Manufacturers PD-1 and PD-L1 Inhibitors Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers PD-1 and PD-L1 Inhibitors Product Location Distribution
3.4.2 Players PD-1 and PD-L1 Inhibitors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PD-1 AND PD-L1 INHIBITORS BY GEOGRAPHIC REGION
4.1 World Historic PD-1 and PD-L1 Inhibitors Market Size by Geographic Region (2020-2025)
4.1.1 Global PD-1 and PD-L1 Inhibitors Annual Sales by Geographic Region (2020-2025)
4.1.2 Global PD-1 and PD-L1 Inhibitors Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic PD-1 and PD-L1 Inhibitors Market Size by Country/Region (2020-2025)
4.2.1 Global PD-1 and PD-L1 Inhibitors Annual Sales by Country/Region (2020-2025)
4.2.2 Global PD-1 and PD-L1 Inhibitors Annual Revenue by Country/Region (2020-2025)
4.3 Americas PD-1 and PD-L1 Inhibitors Sales Growth
4.4 APAC PD-1 and PD-L1 Inhibitors Sales Growth
4.5 Europe PD-1 and PD-L1 Inhibitors Sales Growth
4.6 Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Growth
5 AMERICAS
5.1 Americas PD-1 and PD-L1 Inhibitors Sales by Country
5.1.1 Americas PD-1 and PD-L1 Inhibitors Sales by Country (2020-2025)
5.1.2 Americas PD-1 and PD-L1 Inhibitors Revenue by Country (2020-2025)
5.2 Americas PD-1 and PD-L1 Inhibitors Sales by Type (2020-2025)
5.3 Americas PD-1 and PD-L1 Inhibitors Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC PD-1 and PD-L1 Inhibitors Sales by Region
6.1.1 APAC PD-1 and PD-L1 Inhibitors Sales by Region (2020-2025)
6.1.2 APAC PD-1 and PD-L1 Inhibitors Revenue by Region (2020-2025)
6.2 APAC PD-1 and PD-L1 Inhibitors Sales by Type (2020-2025)
6.3 APAC PD-1 and PD-L1 Inhibitors Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe PD-1 and PD-L1 Inhibitors by Country
7.1.1 Europe PD-1 and PD-L1 Inhibitors Sales by Country (2020-2025)
7.1.2 Europe PD-1 and PD-L1 Inhibitors Revenue by Country (2020-2025)
7.2 Europe PD-1 and PD-L1 Inhibitors Sales by Type (2020-2025)
7.3 Europe PD-1 and PD-L1 Inhibitors Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa PD-1 and PD-L1 Inhibitors by Country
8.1.1 Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Country (2020-2025)
8.1.2 Middle East & Africa PD-1 and PD-L1 Inhibitors Revenue by Country (2020-2025)
8.2 Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Type (2020-2025)
8.3 Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of PD-1 and PD-L1 Inhibitors
10.3 Manufacturing Process Analysis of PD-1 and PD-L1 Inhibitors
10.4 Industry Chain Structure of PD-1 and PD-L1 Inhibitors
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 PD-1 and PD-L1 Inhibitors Distributors
11.3 PD-1 and PD-L1 Inhibitors Customer
12 WORLD FORECAST REVIEW FOR PD-1 AND PD-L1 INHIBITORS BY GEOGRAPHIC REGION
12.1 Global PD-1 and PD-L1 Inhibitors Market Size Forecast by Region
12.1.1 Global PD-1 and PD-L1 Inhibitors Forecast by Region (2026-2031)
12.1.2 Global PD-1 and PD-L1 Inhibitors Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global PD-1 and PD-L1 Inhibitors Forecast by Type (2026-2031)
12.7 Global PD-1 and PD-L1 Inhibitors Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
13.1.3 Merck PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Bristol-Myers Squibb
13.2.1 Bristol-Myers Squibb Company Information
13.2.2 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
13.2.3 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Bristol-Myers Squibb Main Business Overview
13.2.5 Bristol-Myers Squibb Latest Developments
13.3 Roche
13.3.1 Roche Company Information
13.3.2 Roche PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
13.3.3 Roche PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Roche Main Business Overview
13.3.5 Roche Latest Developments
13.4 AstraZeneca
13.4.1 AstraZeneca Company Information
13.4.2 AstraZeneca PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
13.4.3 AstraZeneca PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 AstraZeneca Main Business Overview
13.4.5 AstraZeneca Latest Developments
13.5 Ono Pharmaceutical
13.5.1 Ono Pharmaceutical Company Information
13.5.2 Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
13.5.3 Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Ono Pharmaceutical Main Business Overview
13.5.5 Ono Pharmaceutical Latest Developments
13.6 Regeneron
13.6.1 Regeneron Company Information
13.6.2 Regeneron PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
13.6.3 Regeneron PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Regeneron Main Business Overview
13.6.5 Regeneron Latest Developments
13.7 Innovent
13.7.1 Innovent Company Information
13.7.2 Innovent PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
13.7.3 Innovent PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Innovent Main Business Overview
13.7.5 Innovent Latest Developments
13.8 Hengrui Medicine
13.8.1 Hengrui Medicine Company Information
13.8.2 Hengrui Medicine PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
13.8.3 Hengrui Medicine PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Hengrui Medicine Main Business Overview
13.8.5 Hengrui Medicine Latest Developments
13.9 Junshi Biosciences
13.9.1 Junshi Biosciences Company Information
13.9.2 Junshi Biosciences PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
13.9.3 Junshi Biosciences PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Junshi Biosciences Main Business Overview
13.9.5 Junshi Biosciences Latest Developments
13.10 Merck KGaA
13.10.1 Merck KGaA Company Information
13.10.2 Merck KGaA PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
13.10.3 Merck KGaA PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Merck KGaA Main Business Overview
13.10.5 Merck KGaA Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. PD-1 and PD-L1 Inhibitors Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. PD-1 and PD-L1 Inhibitors Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of PD-1 Inhibitors
Table 4. Major Players of PD-L1 Inhibitors
Table 5. Global PD-1 and PD-L1 Inhibitors Sales byType (2020-2025) & (L)
Table 6. Global PD-1 and PD-L1 Inhibitors Sales Market Share byType (2020-2025)
Table 7. Global PD-1 and PD-L1 Inhibitors Revenue byType (2020-2025) & ($ million)
Table 8. Global PD-1 and PD-L1 Inhibitors Revenue Market Share byType (2020-2025)
Table 9. Global PD-1 and PD-L1 Inhibitors Sale Price byType (2020-2025) & (USD/ml)
Table 10. Global PD-1 and PD-L1 Inhibitors Sale by Application (2020-2025) & (L)
Table 11. Global PD-1 and PD-L1 Inhibitors Sale Market Share by Application (2020-2025)
Table 12. Global PD-1 and PD-L1 Inhibitors Revenue by Application (2020-2025) & ($ million)
Table 13. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Application (2020-2025)
Table 14. Global PD-1 and PD-L1 Inhibitors Sale Price by Application (2020-2025) & (USD/ml)
Table 15. Global PD-1 and PD-L1 Inhibitors Sales by Company (2020-2025) & (L)
Table 16. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Company (2020-2025)
Table 17. Global PD-1 and PD-L1 Inhibitors Revenue by Company (2020-2025) & ($ millions)
Table 18. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Company (2020-2025)
Table 19. Global PD-1 and PD-L1 Inhibitors Sale Price by Company (2020-2025) & (USD/ml)
Table 20. Key Manufacturers PD-1 and PD-L1 Inhibitors Producing Area Distribution and Sales Area
Table 21. Players PD-1 and PD-L1 Inhibitors Products Offered
Table 22. PD-1 and PD-L1 Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global PD-1 and PD-L1 Inhibitors Sales by Geographic Region (2020-2025) & (L)
Table 26. Global PD-1 and PD-L1 Inhibitors Sales Market Share Geographic Region (2020-2025)
Table 27. Global PD-1 and PD-L1 Inhibitors Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global PD-1 and PD-L1 Inhibitors Sales by Country/Region (2020-2025) & (L)
Table 30. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Country/Region (2020-2025)
Table 31. Global PD-1 and PD-L1 Inhibitors Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas PD-1 and PD-L1 Inhibitors Sales by Country (2020-2025) & (L)
Table 34. Americas PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2020-2025)
Table 35. Americas PD-1 and PD-L1 Inhibitors Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas PD-1 and PD-L1 Inhibitors Sales byType (2020-2025) & (L)
Table 37. Americas PD-1 and PD-L1 Inhibitors Sales by Application (2020-2025) & (L)
Table 38. APAC PD-1 and PD-L1 Inhibitors Sales by Region (2020-2025) & (L)
Table 39. APAC PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2020-2025)
Table 40. APAC PD-1 and PD-L1 Inhibitors Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC PD-1 and PD-L1 Inhibitors Sales byType (2020-2025) & (L)
Table 42. APAC PD-1 and PD-L1 Inhibitors Sales by Application (2020-2025) & (L)
Table 43. Europe PD-1 and PD-L1 Inhibitors Sales by Country (2020-2025) & (L)
Table 44. Europe PD-1 and PD-L1 Inhibitors Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe PD-1 and PD-L1 Inhibitors Sales byType (2020-2025) & (L)
Table 46. Europe PD-1 and PD-L1 Inhibitors Sales by Application (2020-2025) & (L)
Table 47. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Country (2020-2025) & (L)
Table 48. Middle East & Africa PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales byType (2020-2025) & (L)
Table 50. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Application (2020-2025) & (L)
Table 51. Key Market Drivers & Growth Opportunities of PD-1 and PD-L1 Inhibitors
Table 52. Key Market Challenges & Risks of PD-1 and PD-L1 Inhibitors
Table 53. Key IndustryTrends of PD-1 and PD-L1 Inhibitors
Table 54. PD-1 and PD-L1 Inhibitors Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. PD-1 and PD-L1 Inhibitors Distributors List
Table 57. PD-1 and PD-L1 Inhibitors Customer List
Table 58. Global PD-1 and PD-L1 Inhibitors SalesForecast by Region (2026-2031) & (L)
Table 59. Global PD-1 and PD-L1 Inhibitors RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas PD-1 and PD-L1 Inhibitors SalesForecast by Country (2026-2031) & (L)
Table 61. Americas PD-1 and PD-L1 Inhibitors Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC PD-1 and PD-L1 Inhibitors SalesForecast by Region (2026-2031) & (L)
Table 63. APAC PD-1 and PD-L1 Inhibitors Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe PD-1 and PD-L1 Inhibitors SalesForecast by Country (2026-2031) & (L)
Table 65. Europe PD-1 and PD-L1 Inhibitors RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa PD-1 and PD-L1 Inhibitors SalesForecast by Country (2026-2031) & (L)
Table 67. Middle East & Africa PD-1 and PD-L1 Inhibitors RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global PD-1 and PD-L1 Inhibitors SalesForecast byType (2026-2031) & (L)
Table 69. Global PD-1 and PD-L1 Inhibitors RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global PD-1 and PD-L1 Inhibitors SalesForecast by Application (2026-2031) & (L)
Table 71. Global PD-1 and PD-L1 Inhibitors RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Merck Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
Table 74. Merck PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2020-2025)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. Bristol-Myers Squibb Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 78. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
Table 79. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2020-2025)
Table 80. Bristol-Myers Squibb Main Business
Table 81. Bristol-Myers Squibb Latest Developments
Table 82. Roche Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 83. Roche PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
Table 84. Roche PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2020-2025)
Table 85. Roche Main Business
Table 86. Roche Latest Developments
Table 87. AstraZeneca Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 88. AstraZeneca PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
Table 89. AstraZeneca PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2020-2025)
Table 90. AstraZeneca Main Business
Table 91. AstraZeneca Latest Developments
Table 92. Ono Pharmaceutical Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 93. Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
Table 94. Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2020-2025)
Table 95. Ono Pharmaceutical Main Business
Table 96. Ono Pharmaceutical Latest Developments
Table 97. Regeneron Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 98. Regeneron PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
Table 99. Regeneron PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2020-2025)
Table 100. Regeneron Main Business
Table 101. Regeneron Latest Developments
Table 102. Innovent Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 103. Innovent PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
Table 104. Innovent PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2020-2025)
Table 105. Innovent Main Business
Table 106. Innovent Latest Developments
Table 107. Hengrui Medicine Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 108. Hengrui Medicine PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
Table 109. Hengrui Medicine PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2020-2025)
Table 110. Hengrui Medicine Main Business
Table 111. Hengrui Medicine Latest Developments
Table 112. Junshi Biosciences Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 113. Junshi Biosciences PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
Table 114. Junshi Biosciences PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2020-2025)
Table 115. Junshi Biosciences Main Business
Table 116. Junshi Biosciences Latest Developments
Table 117. Merck KGaA Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 118. Merck KGaA PD-1 and PD-L1 Inhibitors Product Portfolios and Specifications
Table 119. Merck KGaA PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2020-2025)
Table 120. Merck KGaA Main Business
Table 121. Merck KGaA Latest Developments
LIST OFFIGURES
Figure 1. Picture of PD-1 and PD-L1 Inhibitors
Figure 2. PD-1 and PD-L1 Inhibitors Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global PD-1 and PD-L1 Inhibitors Sales Growth Rate 2020-2031 (L)
Figure 7. Global PD-1 and PD-L1 Inhibitors Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. PD-1 and PD-L1 Inhibitors Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. PD-1 and PD-L1 Inhibitors Sales Market Share by Country/Region (2024)
Figure 10. PD-1 and PD-L1 Inhibitors Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of PD-1 Inhibitors
Figure 12. Product Picture of PD-L1 Inhibitors
Figure 13. Global PD-1 and PD-L1 Inhibitors Sales Market Share byType in 2025
Figure 14. Global PD-1 and PD-L1 Inhibitors Revenue Market Share byType (2020-2025)
Figure 15. PD-1 and PD-L1 Inhibitors Consumed in SolidTumors
Figure 16. Global PD-1 and PD-L1 Inhibitors Market: SolidTumors (2020-2025) & (L)
Figure 17. PD-1 and PD-L1 Inhibitors Consumed in Blood-relatedTumors
Figure 18. Global PD-1 and PD-L1 Inhibitors Market: Blood-relatedTumors (2020-2025) & (L)
Figure 19. Global PD-1 and PD-L1 Inhibitors Sale Market Share by Application (2024)
Figure 20. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Application in 2025
Figure 21. PD-1 and PD-L1 Inhibitors Sales by Company in 2025 (L)
Figure 22. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Company in 2025
Figure 23. PD-1 and PD-L1 Inhibitors Revenue by Company in 2025 ($ millions)
Figure 24. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Company in 2025
Figure 25. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Geographic Region in 2025
Figure 27. Americas PD-1 and PD-L1 Inhibitors Sales 2020-2025 (L)
Figure 28. Americas PD-1 and PD-L1 Inhibitors Revenue 2020-2025 ($ millions)
Figure 29. APAC PD-1 and PD-L1 Inhibitors Sales 2020-2025 (L)
Figure 30. APAC PD-1 and PD-L1 Inhibitors Revenue 2020-2025 ($ millions)
Figure 31. Europe PD-1 and PD-L1 Inhibitors Sales 2020-2025 (L)
Figure 32. Europe PD-1 and PD-L1 Inhibitors Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales 2020-2025 (L)
Figure 34. Middle East & Africa PD-1 and PD-L1 Inhibitors Revenue 2020-2025 ($ millions)
Figure 35. Americas PD-1 and PD-L1 Inhibitors Sales Market Share by Country in 2025
Figure 36. Americas PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2020-2025)
Figure 37. Americas PD-1 and PD-L1 Inhibitors Sales Market Share byType (2020-2025)
Figure 38. Americas PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2020-2025)
Figure 39. United States PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC PD-1 and PD-L1 Inhibitors Sales Market Share by Region in 2025
Figure 44. APAC PD-1 and PD-L1 Inhibitors Revenue Market Share by Region (2020-2025)
Figure 45. APAC PD-1 and PD-L1 Inhibitors Sales Market Share byType (2020-2025)
Figure 46. APAC PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2020-2025)
Figure 47. China PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 51. India PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Country in 2025
Figure 55. Europe PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2020-2025)
Figure 56. Europe PD-1 and PD-L1 Inhibitors Sales Market Share byType (2020-2025)
Figure 57. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2020-2025)
Figure 58. Germany PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 59.France PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 60. UK PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Market Share byType (2020-2025)
Figure 65. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2020-2025)
Figure 66. Egypt PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 69.Turkey PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries PD-1 and PD-L1 Inhibitors Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of PD-1 and PD-L1 Inhibitors in 2025
Figure 72. Manufacturing Process Analysis of PD-1 and PD-L1 Inhibitors
Figure 73. Industry Chain Structure of PD-1 and PD-L1 Inhibitors
Figure 74. Channels of Distribution
Figure 75. Global PD-1 and PD-L1 Inhibitors Sales MarketForecast by Region (2026-2031)
Figure 76. Global PD-1 and PD-L1 Inhibitors Revenue Market ShareForecast by Region (2026-2031)
Figure 77. Global PD-1 and PD-L1 Inhibitors Sales Market ShareForecast byType (2026-2031)
Figure 78. Global PD-1 and PD-L1 Inhibitors Revenue Market ShareForecast byType (2026-2031)
Figure 79. Global PD-1 and PD-L1 Inhibitors Sales Market ShareForecast by Application (2026-2031)
Figure 80. Global PD-1 and PD-L1 Inhibitors Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Pulmonary Function Testing Systems Market Growth 2025-2031
US$ 3,660.00
March 2025
111 pages
Global Wound Protector Market Growth 2023-2029
US$ 3,660.00
March 2023
126 pages
Global Automated Multi-Purpose Workstation Market Growth 2024-2030
US$ 3,660.00
December 2024
113 pages
Global Ostomy Products Market Growth 2025-2031
US$ 3,660.00
March 2025
110 pages
